Office for Human Research
Studies
450 Brookline Avenue, OS229
DANA-FARBER / HARVARD CANCER CENTER Boston, MA 02215
Phone: 617 632-3029
Fax: 617 632-2686
Date:
To Whom It May Concern:
Please be advised that the Dana-Farber Cancer Institute (DFCI) operates in full compliance with all DHHS, FDA and Massachusetts regulations governing the use of human subjects in research. DFCI has a Federal Wide Assurance (FWA) on file with the Office for Human Research Protections (OHRP) and our institutional review boards (IRB) are all registered with OHRP.
Dana-Farber Cancer Institute:
FWA# 00001121 expires September 5, 2019
IORG# 0000035 expires on June 13, 2020
DFCI IRB Registration Numbers:
Version: 06.26.2017
Office for Human Research
Studies
450 Brookline Avenue, OS229
DANA-FARBER / HARVARD CANCER CENTER Boston, MA 02215
Phone: 617 632-3029
Fax: 617 632-2686
IRB00000052 (#1 / Panel A)
IRB00000753 (#2 / Panel B)
IRB00001186 (#3 / Panel C)
IRB00003340 (#4 / Panel D)
IRB00005504 (#5 / Panel E)
IRB00006224 (#6 / Panel F)
IRB00007493 (#7 / Panel G)
The DFCI IRBs are the designated IRBs of record for all oncology protocols for the clinical institutions that comprise the Dana-Farber/Harvard Cancer Center (DF/HCC) consortium, including Beth Israel Deaconess Medical Center (BIDMC), Boston Children’s Hospital (BCH), Brigham and Women’s Hospital (BWH), Dana-Farber Cancer Institute (DFCI), and Massachusetts General Hospital (MGH). Additionally, the DFCI IRBs serve as the IRBs of record for several affiliated institutions pursuant to inter-institutional agreements.
The DFCI IRB does not post its IRB rosters nor do we release names of IRB members. However, any IRB member who is an investigator, co-investigator or has any other conflict of interest with a protocol under review by the IRB will not participate in the vote of that protocol although he or she may be called upon to answer questions during the review.
The DFCI IRB does not require its IRB Chairs or any other member of the IRB to sign approval documents. There is no regulatory requirement for such signatures. These documents are generated by the staff of the DFCI Office for Human Research Studies (OHRS), which is the office that manages scientific and IRB review for DF/HCC. If you require additional information please contact our office at the number listed above.
Sincerely,
Emily Eldh, CIP
Director
DFCI IRB Protocol #:
Cooperative Group Protocol #:
DF/HCC Principal Investigator:
The attached DFCI IRB Approval covers the following checked institution(s):
Version: 06.26.17
Dana-Farber Cancer Institute:
FWA# 00001121
IORG# 0000035
Office for Human Research
Studies
450 Brookline Avenue, OS229
DANA-FARBER / HARVARD CANCER CENTER Boston, MA 02215
Phone: 617 632-3029
Fax: 617 632-2686
Approval Description:
Version: 06.26.17
Dana-Farber Cancer Institute:
FWA# 00001121
IORG# 0000035
Office for Human Research
Studies
450 Brookline Avenue, OS229
DANA-FARBER / HARVARD CANCER CENTER Boston, MA 02215
Phone: 617 632-3029
Fax: 617 632-2686
BIDMC INST#: MA038
BCH INST#: MA042
BWH INST#: MA037
DFCI INST#: MA036
DFCI/NHOH @ Londonderry INST#: NH043
DFCI @ Milford Hospital INST#: MA188
DFCI @ South Shore INST#: MA185
DFCI @ Steward St. Elizabeth’s INST#: MA049
MGH INST #: MA034
MGH @ North Shore Cancer Center INST#: MA093
MGH @ Emerson-Bethke INST#: MA100
Cape Cod HealthCare INST#: MA078 FWA#: 00001747
Lowell General Hospital INST#: MA134 FWA#: 00001027
Newton-Wellesley Hospital INST#: MA056 FWA#: 00000799
New Hampshire Onc-Hem, PA INST#: NH015 FWA#: 00004392
Version: 06.26.17
Dana-Farber Cancer Institute:
FWA# 00001121
IORG# 0000035
Office for Human Research
Studies
450 Brookline Avenue, OS229
DANA-FARBER / HARVARD CANCER CENTER Boston, MA 02215
Phone: 617 632-3029
Fax: 617 632-2686
INST Name: INST#: FWA#:
INST Name: INST#: FWA#:
INST Name: INST#: FWA#:
INST Name: INST#: FWA#:
Version: 11.08.12